www.techcrunch.com
When TechCrunch asks Flowrite if it’s ‘Grammarly on steroids’, CEO and co-founder Aaro Isosaari laughs, saying that’s the comment they always get for the AI writing productivity tool they’ve been building since late summer 2020 — drawing on early access to OpenAI’s GPT-3 API, and attracting a wait-list of some 30,000 email-efficiency seeking prosumers keen to get their typing fingers on its beta.
